Vergote et al., 2010) or with carboplatin plus paclitaxel (Sequist et al., 2009)
Andrew Huberman notes that despite its popularity and extensive animal studies, there is only one poorly conducted human study, leaving much about its behavior in the human body, including its pharmacokinetics, still unknown 2
We believe that when you provide the body with clean, bioavailable nutrients, it has the tools it needs to thrive on its own terms
GHK-Cu rebuilds structural proteins rather than just suppressing inflammation
This present study not only revealed the expression changes of vasoactive intestinal peptide [and its] receptors within human nucleus pulposus tissue, but also demonstrated [its] protective effects [against] degeneration, said Jingchuan Sun, professor in the Department of Orthopedic Surgery in Changzheng Hospital, and co-lead author of the study